ITGRHealthcare · Medical DevicesThe 9 Wall Street analysts covering Integer Holdings Corp. hold a median 12-month price target of $127 — +1.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 71 of 100 as at 15 Aug 2026 — in the upper half. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Integer Holdings Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Volatility (94): The share price has been relatively steady.
Accruals (47): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.
Size (26): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on ITGR, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +1.4% from it.
Of the 20 most recent actions, 3 moved their price target up and 0 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 4 Aug 2026 | Freedom Capital Markets | Downgrade | Hold | — |
| 4 Aug 2026 | Oppenheimer | Downgrade | Perform | — |
| 4 Aug 2026 | Truist Securities | Downgrade | Hold | $110 → $127 |
| 4 Aug 2026 | Wells Fargo | Maintains | Equal-Weight | $84 → $127 |
| 3 Aug 2026 | Keybanc | Downgrade | Sector Weight | — |
| 22 July 2026 | Freedom Capital Markets | Initiates | Buy | $112 |
| 22 July 2026 | Freedom Capital Markets | Initiates | Buy | — |
| 16 July 2026 | Truist Securities | Maintains | Buy | $97 → $110 |
| 16 July 2026 | Truist Securities | Maintains | Buy | — |
| 8 July 2026 | Citigroup | Maintains | Neutral | — |
| 28 May 2026 | Citigroup | Maintains | Neutral | — |
| 13 May 2026 | Oppenheimer | Upgrade | Outperform | — |
| 1 May 2026 | Citigroup | Maintains | Neutral | — |
| 1 May 2026 | Piper Sandler | Reiterates | Overweight | — |
| 20 Feb 2026 | Benchmark | Upgrade | Buy | — |
| 20 Feb 2026 | Citigroup | Maintains | Neutral | — |
| 20 Feb 2026 | Truist Securities | Maintains | Buy | — |
| 20 Feb 2026 | Wells Fargo | Maintains | Equal-Weight | — |
| 18 Dec 2025 | Truist Securities | Maintains | Buy | — |
| 11 Dec 2025 | Citigroup | Maintains | Neutral | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ITGR appears on the weeks it earns a place.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 24% of US stocks
Cheaper than 50% of US stocks
Cheaper than 40% of US stocks
Cheaper than 21% of US stocks
Higher than 23% of US stocks
Higher than 13% of US stocks
Higher than 27% of US stocks
Higher than 64% of US stocks
Higher than 64% of US stocks
Higher than 58% of US stocks
Higher than 70% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Integer Holdings Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Zacks Investment Research published a comparison of Globus Medical (GMED) and Integer (ITGR), examining which stock offers better value for investors interested in medical instruments companies.
Why it matters — The article positions Integer against a peer in the medical instruments sector, which could influence how value-oriented investors perceive ITGR's relative attractiveness.
Integer Holdings reported Q2 earnings and revenue that exceeded analyst estimates, but sales and margins declined due to ongoing product headwinds ahead of its $5.7 billion deal with KKR.
Why it matters — The results show ITGR beating expectations on the top and bottom lines even as operational challenges persist, offering a mixed picture for investors watching the company's performance ahead of its pending acquisition by KKR.
Kahn Swick & Foti, LLC is investigating the proposed sale of Integer Holdings Corporation to KKR, under which shareholders would receive $127.00 in cash per share. The law firm is examining whether the consideration and the process leading to the deal are adequate.
Why it matters — The investigation raises questions about the fairness of the proposed acquisition price and process for Integer Holdings shareholders.
Law firm Ademi LLP announced it is investigating Integer Holdings Corp. (NYSE: ITGR) for possible breaches of fiduciary duty and other violations of law related to the company's recently announced transaction with KKR, questioning whether public shareholders are receiving a fair price.
Why it matters — ITGR watchers would care because the investigation could signal concerns about the terms of the announced KKR transaction and the value offered to public shareholders.
Integer (ITGR) reported its Q2 2026 earnings, with the article suggesting that investors compare its key metrics against Wall Street estimates and prior-year results.
Why it matters — The piece provides a framework for evaluating how Integer's quarterly performance measures up against analyst expectations and historical results.
The 9 Wall Street analysts covering Integer Holdings Corp. have a median 12-month price target of $127, with estimates ranging from $95 to $127. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 9 analysts covering Integer Holdings Corp., 1 rate it a Buy, 8 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Integer Holdings Corp. 71 out of 100 across roughly 4,600 US stocks as at 15 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 15 Aug 2026, Integer Holdings Corp. ranks 71 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (94 of 100).
No one can know that. What the data says: the median 12-month target from 9 analysts implies +1.4% from the last close, and Ticker Nerd's factor model ranks Integer Holdings Corp. 71 out of 100 as at 15 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Integer Holdings Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ITGR are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $95 to $127 over the next 12 months.
Integer Holdings Corp. returned +17.3% over the 12 months to 14 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
Integer Holdings Corporation is one of the largest medical device contract development and manufacturing organizations (CDMOs) in the world. It serves the cardio and vascular, neuromodulation, and cardiac rhythm management markets by providing industry-leading engineering and manufacturing solutions to original equipment manufacturers and medical device companies.
The most recent item we track (Zacks Investment Research, 11 Aug 2026): "GMED vs. ITGR: Which Stock Is the Better Value Option?". Zacks Investment Research published a comparison of Globus Medical (GMED) and Integer (ITGR), examining which stock offers better value for investors interested in medical instruments companies.
Integer Holdings Corporation is one of the largest medical device contract development and manufacturing organizations (CDMOs) in the world. It serves the cardio and vascular, neuromodulation, and cardiac rhythm management markets by providing industry-leading engineering and manufacturing solutions to original equipment manufacturers and medical device companies. As a strategic partner, Integer Holdings Corporation advances customer goals through high-quality products, innovative components, and a commitment to service and quality. The company operates under prominent brands including Greatbatch Medical and Lake Region Medical, focusing on complex medical device components essential for patient care worldwide. It also develops batteries for nonmedical applications in energy, military, and environmental markets. Integer Holdings Corporation plays a vital role in the medical device industry by enabling innovation and production efficiency for OEMs across these specialized sectors. Founded in 1970 and headquartered in Plano, Texas, it maintains strong long-term customer relationships and a diversified portfolio in high-growth medical markets.
CEO Mr. Payman Khales · 11,000 employees · United States · https://www.integer.net